Despite the slower growth in share price compared to earning...

Despite the slower growth in share price compared to earnings per share, the market remains optimistic about Neurocrine Biosciences, as indicated by its high P/E ratio. The recent positive sentiment and strong share price momentum may present an investment opportunity.